Tech Company Financing Transactions
MycoMedica Life Sciences Funding Round
MycoMedica Life Sciences secured a $60 million investment round on 6/1/2022. Investors included Obvious Ventures, Kitty Hawk Capital and True Ventures.
Transaction Overview
Company Name
Announced On
6/1/2022
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds from the financing will be used to advance the company's next stage of operations on the path to FDA approval for an Investigational New Drug Application (IND) -- pre-clinical research and initial clinical trials of the Stamets Stack.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
50 Southeast Nelson Rd.
Shelton, WA 98584
USA
Shelton, WA 98584
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
MycoMedica, PBC is a lifesciences company developing therapeutic drugs derived from fungi to help people live healthier, better lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Stamets
Chief Financial Officer
Tad Buchanan
Chief Medical Officer
Sanjay Dubé
Chief Scientific Officer
Nick Moore
Co-Founder
Pamela Kryskow
VP - Operations
Joanna Bolger
Browse more venture capital transactions:
Prev: 6/1/2022: Code Intelligence venture capital transaction
Next: 6/2/2022: Poparazzi venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs